A generic version of Lipitor is being recalled after some batches were found to contain glass particles.
Indian drugmaker Ranbaxy Laboratories said it issued the recall because of its generic version of Pfizer Inc.’s Lipitor because after it learned that some lots of its 10-, 20- and 40-milligram doses of the drug may contain glass. Ranbaxy also said there have been no reported injuries.
With everyone and their mother using Lipitor these days, there is fear that there will shortages in this cholesterol-lowering drug.
Of some concern is that Ranbaxy, which has a lot of market share of generic Lipitor, is a frequent flyer on the trouble train. In 2008, the FDA took the extraordinary step of banned Ranbaxy from importing a number of drugs after it learned of manufacturing deficiencies at its manufacturing plants and, more troubling, that it falsied data submitted for drug applications. This issue is beting resolved with the FDA and the Justice Department at the tune of around a half a billion dollars.